Compass ups stake in Rameda: Rameda Pharma’s largest shareholder Equinox Pharma has raised its stake in the company by 2.7% to 15.4%, the company said in a statement (pdf) last night. Equinox is owned by Compass Investment, which acquired 100% of Rameda in 2011 before listing it on the EGX in 2019.

What they said: “We look forward to further solidifying Rameda’s decade-long relationship with our main shareholder, Equinox./ We believe that the transaction underscores Equinox’s continued confidence in Rameda’s ability to deliver sustainable long-term growth and value creation,” said Rameda CEO Amr Morsy.

Tags: